SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — Mary McLeod Bethune

PatientMary McLeod Bethune
Date of birth1953-07-10
IdentifiersMRN HR-ML043-SYN; SSN (made up) 000-43-2195
Document date2026-06-15
AuthorViola Harrington-Mbeki, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Worsening wheeze and breathlessness for two days with a cold. [S]

History of Present Illness

Mrs. Bethune called the clinic this morning from the yellow zone of her action plan and was seen the same day. Five days ago she developed a cold with a runny nose and sore throat after a crowded church gathering. For two days her wheeze and chest tightness have worsened; she woke three times last night and has needed eight extra inhalations of budesonide-formoterol in each of the last two days, as her plan allows. Her morning peak flow has fallen from about 300 to 210 L/min. She can speak in full sentences and has no chest pain. She has no fever, green sputum or leg swelling, and has had no ankle swelling or orthopnea that would suggest heart failure. She takes her maintenance inhalations with the spacer, amlodipine and atorvastatin as prescribed. She has never been admitted to hospital for asthma or needed a breathing tube. [S]

ElementDetail
OnsetCold five days ago; asthma worse for two days
SeverityWoke three times last night; eight reliever inhalations a day; morning peak flow 210 L/min
ContextLow-dose budesonide-formoterol maintenance and reliever; yellow zone of her action plan
Associated signs and symptomsRunny nose and sore throat; no fever, chest pain, purulent sputum or leg swelling
Risk historyNo previous admission, intensive care or intubation for asthma; no oral corticosteroid in the past year

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired; temperature 37.4 °C; no rigors
RespiratoryPositiveWheeze, chest tightness and night waking; dry cough; no hemoptysis
Ears, nose, mouth, and throatPositiveRunny nose and sore throat
CardiovascularNegativeNo chest pain, orthopnea or ankle swelling

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 mcg/actuation inhaler, two puffs as needed, from an urgent care visit four months ago (used alone, without an inhaled steroid)Two puffs every 4 hours as needed; she uses it most daysRespiratory tract route2025-11-03 to 2026-03-23completedS
Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning for five days40 mg each morning for five daysOral route2026-06-15 to 2026-06-19completedS
Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 3): one inhalation twice daily and one inhalation as needed for symptoms, no more than 12 inhalations a dayOne inhalation twice daily plus one as neededRespiratory tract route2026-03-23 to 2026-06-15completedS
Budesonide-formoterol 160/4.5 mcg inhaler with a spacer: two inhalations twice daily and one as needed (stepped up during the exacerbation), no more than 12 inhalations a dayTwo inhalations twice daily plus one as neededRespiratory tract route2026-06-15 to 2026-07-27completedS
Fluticasone propionate 50 mcg/actuation nasal spray, two sprays in each nostril once daily, aimed away from the septumTwo sprays each nostril dailyNasal route2026-03-23activeS
Sodium chloride 0.65% nasal spray, two sprays in each nostril up to four times daily before the steroid sprayTwo sprays each nostril up to four times dailyNasal route2026-03-23activeS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-23activeS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-23activeS
Omeprazole 20 mg delayed-release capsule, one capsule daily 30 minutes before breakfast for eight weeksOne capsule daily before breakfastOral route2026-03-23 to 2026-05-18completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-15Body height163cmS
2026-06-15Body weight87.2kgS
2026-06-15Body mass index (BMI) [Ratio]32.8kg/m2S
2026-06-15Systolic blood pressure138mm[Hg]S
2026-06-15Diastolic blood pressure82mm[Hg]S
2026-06-15Heart rate98/minS
2026-06-15Respiratory rate22/minS
2026-06-15Body temperature37.4CelS
2026-06-15Oxygen saturation in Arterial blood by Pulse oximetry94%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-15Maximum expiratory gas flow Respiratory system airway by Peak flow meter205L/min80 percent of her personal best of 340 L/minLowS

Physical Exam

Vital signs recorded on 2026-06-15; see the Vital Signs section. [S]

SystemFinding
GeneralAlert, sitting upright, speaking in full sentences; not using accessory muscles
Vital signsPulse 98, respiratory rate 22, oxygen saturation 94 percent on room air, temperature 37.4 °C; peak flow 205 L/min (60 percent of her best)
Head, eyes, ears, nose, and throatRed throat; clear nasal discharge
RespiratoryWidespread expiratory wheeze with good air entry; no crackles
CardiovascularRegular rhythm; jugular venous pressure not raised; no edema
Reassessment after one hourAfter albuterol 8 puffs by spacer three times over an hour: peak flow 275 L/min (81 percent), oxygen saturation 96 percent, pulse 92, wheeze much reduced

Problems

ProblemClinical statusVerificationCodeProvenance
Wheeze, cough and breathlessness for four months: waking with cough and tight chest two or three nights a week, breathless on one flight of stairs, relieved by albuterol, worse with colds, dust and strong scents; known asthma for many years but never confirmed by lung function testing and never treated with an inhaled steroid. Asthma, COPD and heart failure to be distinguished: spirometry with bronchodilator response, FeNO and an echocardiogram bookedresolvedconfirmed R06.2S — Synthetic presenting problem anchored to her documented chronic asthma. Superseded by the diagnosis at the second visit.
Blocked nose, thick postnasal drip and a reduced sense of smell for years, worse in the last year; no nosebleeds; never seen by an ear, nose and throat specialistresolvedconfirmed R09.81S — Synthetic upper-airway symptoms; superseded by the diagnosis of chronic rhinosinusitis after nasal endoscopy.
Gastro-esophageal reflux: heartburn and an acid taste two or three evenings a week, worse after late meals and lying down; no trouble swallowing, vomiting, black stools or weight lossactiveconfirmed K21.9S — Synthetic comorbidity of asthma; not a claim about her real health.
Obesity, class 1 (BMI 33.1); she wants to walk more and to keep up with her work, and agreed to talk about itactiveconfirmed E66.811S — Synthetic comorbidity recorded in her words and with her agreement; not a claim about her real weight.
Moderate asthma exacerbation triggered by a cold: two days of worsening wheeze and night waking despite eight reliever inhalations a day, peak flow 205 L/min (60 percent of her best), oxygen saturation 94 percent; improved to 275 L/min in clinic; treated without admission; resolvedactiveconfirmed J45.41S — Synthetic exacerbation; not a claim about a real attack.
Asthma, confirmed: variable airflow obstruction (FEV1 64 percent predicted, rising 270 mL or 21 percent after bronchodilator, with a normal post-bronchodilator FEV1/FVC of 0.72 and normal DLCO); type 2 inflammation (FeNO 46 ppb, blood eosinophils 0.42 x10^3/uL, total IgE 210, house dust mite sensitization); not COPD and not heart failure. Uncontrolled at diagnosis on albuterol aloneactiveconfirmed J45.40S — Synthetic modern confirmation linked to her documented chronic asthma.
Hypertensive heart disease without heart failure: clinic blood pressure 152/88 and 146/86, home average 144/84; mild concentric left ventricular hypertrophy with grade 1 diastolic dysfunction and a normal ejection fraction (62 percent); BNP 48 pg/mLactiveconfirmed I11.9S — Synthetic finding of the modern work-up; not a claim about her real heart.
Hyperlipidemia: LDL cholesterol 144 mg/dL; 10-year ASCVD risk above 20 percent with hypertensionactiveconfirmed E78.5S — Synthetic cardiovascular risk factor.
Chronic rhinosinusitis without nasal polyps: years of congestion, postnasal drip and reduced smell, with mucosal swelling and mucus in both middle meatuses and no polyps on nasal endoscopyactiveconfirmed J32.9S — Synthetic upper-airway comorbidity of asthma; not a claim about her real health.

Assessment and Plan

Guideline basis: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020)

Follow-up: Nurse telephone calls in two and seven days. Clinic review within a week. Emergency care for any red-zone sign. Next scheduled visit 2026-07-27: review six weeks after an exacerbation: control, repeat spirometry and FeNO, biologic assessment, blood pressure and the post-exacerbation plan. [S]